


LiquiCORE lung panel is a Next Generation Sequencing (NGS) based assay that identifies clinically relevant ge-nomic alterations within the 12 genes (ALK, BRAF, EGFR, ERBB2, KRAS, MAP2K1, MET, NRAS, PIK3CA, RET, ROS1 and TP53) that are most frequently altered in Non Small Cell Lung Cancer (NSCLC)